ID

35671

Descripción

Study ID: 103369 Clinical Study ID: 103369 Study Title: A Randomized Phase III Study of Cisplatin Versus Cisplatin plus Topotecan Versus MVAC in Stage IVB, Recurrent or Persistent Squamous Cell Carcinoma of the Cervix Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Topotecan Trade Name: Topotecan Study Indication: Cancer 

Palabras clave

  1. 15/3/19 15/3/19 -
Titular de derechos de autor

GSK group of companies

Subido en

15 de marzo de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Cisplatin and Topotecan Recurrent or Persistent Carcinoma of the Cervix - 103369

GOG Toxicity Case Summary

Administrative data
Descripción

Administrative data

Type
Descripción

Type

Tipo de datos

text

Reported by
Descripción

Reported

Tipo de datos

text

Telephone
Descripción

Telephone

Tipo de datos

integer

Grade
Descripción

Grade

Tipo de datos

text

Protocol Number
Descripción

Protocol Number

Tipo de datos

integer

Treatment Regimen
Descripción

Regimen

Tipo de datos

text

Alias
UMLS CUI [1]
C0949219
Patient Initials
Descripción

Patient Initials

Tipo de datos

text

Alias
NCI Thesaurus ValueDomain
C25191
UMLS CUI-1
C2986440
NCI Thesaurus ObjectClass
C16960
NCI Thesaurus Property
C25536
Name of the hospital
Descripción

Hospital

Tipo de datos

text

Alias
UMLS CUI [1]
C0019994
GOG #
Descripción

Inst.,Prot.,Seq.

Tipo de datos

integer

Demographics
Descripción

Demographics

Date report submitted
Descripción

Date of report

Tipo de datos

date

Age
Descripción

Age

Tipo de datos

integer

Alias
UMLS CUI [1]
C0001779
Weight
Descripción

Weight

Tipo de datos

float

Unidades de medida
  • kg
Alias
UMLS CUI [1]
C0005910
kg
Height
Descripción

Height

Tipo de datos

integer

Unidades de medida
  • cm
Alias
UMLS CUI [1]
C0005890
cm
Body Surface Area (m^2)
Descripción

Body Surface Area

Tipo de datos

float

Alias
NCI Thesaurus ValueDomain
C25209
UMLS CUI-1
C0005902
NCI Thesaurus ObjectClass
C16960
NCI Thesaurus Property
C25157
Diagnosis
Descripción

Diagnosis

Tipo de datos

text

Alias
UMLS CUI [1]
C0011900
Description
Descripción

Description

Type of previous treatment
Descripción

Type of treatment

Tipo de datos

integer

Start date of administration
Descripción

Administration Start Date

Tipo de datos

date

End date of administration
Descripción

Administration End Date

Tipo de datos

date

Drug
Descripción

Drug

Tipo de datos

text

Alias
UMLS CUI [1]
C2347852
Total Daily Dose
Descripción

Total Daily Dose

Tipo de datos

text

Alias
UMLS CUI [1]
C2348070
Route
Descripción

Route

Tipo de datos

text

Alias
UMLS CUI [1]
C0013153
Protocol Treatment
Descripción

Protocol Treatment

Date this protocol was initiated
Descripción

Date of protocol initiation

Tipo de datos

date

previous toxicity on this protocol
Descripción

previous toxicity on this protocol

Tipo de datos

text

Course # for this toxicity
Descripción

SAE course

Tipo de datos

integer

Date this course started
Descripción

Date course started

Tipo de datos

date

Drugs and Doses for this Course
Descripción

Drugs and Doses for this Course

Drug
Descripción

Please record all drugs and doses for this course only

Tipo de datos

text

Dose
Descripción

Dose

Tipo de datos

text

Route
Descripción

Route

Tipo de datos

text

Cumulative Totals to Date
Descripción

Cumulative Totals to Date

Drug
Descripción

Please record all drugs and doses to date

Tipo de datos

text

Dose
Descripción

Dose

Tipo de datos

text

Route
Descripción

Route

Tipo de datos

text

Serious Adverse Event
Descripción

Serious Adverse Event

Was patient hospitalized for reaction?
Descripción

Hospitalization

Tipo de datos

text

Was treatment with suspected drug reduced in dosage?
Descripción

drug dose reduced

Tipo de datos

text

Did reaction abate?
Descripción

SAE reaction

Tipo de datos

text

Was drug reintroduced or dose increased?
Descripción

drug re-introduction

Tipo de datos

text

Did reaction reappear?
Descripción

SAE reaction reappear

Tipo de datos

text

Pretreatment Counts for this Course
Descripción

Pretreatment Counts for this Course

Test
Descripción

Test

Tipo de datos

integer

Date taken
Descripción

Date

Tipo de datos

date

Nadir Counts
Descripción

Nadir Counts

Test
Descripción

Test

Tipo de datos

integer

Date taken
Descripción

Date taken

Tipo de datos

date

GOG #
Descripción

GOG #

Sites of metastatic disease?
Descripción

Disease sites

Tipo de datos

text

Concurrent non-malignant disease?
Descripción

Concurrent non-malignant disease

Tipo de datos

text

Concurrent non-protocol medication?
Descripción

Concurrent non-protocol medication

Tipo de datos

text

History of any major organ dysfunctions?
Descripción

history of organ dysfunctions

Tipo de datos

text

Comment
Descripción

Sequence of events leading up to and/or ralted to ADR

Tipo de datos

text

Quality of Life Cover Sheet (Investigator's details)
Descripción

Quality of Life Cover Sheet (Investigator's details)

Date of Form
Descripción

Date

Tipo de datos

date

Patient name
Descripción

Patient name

Tipo de datos

text

Alias
UMLS CUI [1]
C1299487
GOG #
Descripción

Inst.,Prot.,Seq.

Tipo de datos

integer

Time of Today's Assessment
Descripción

Time of Today's Assessment

Cisplatin or Cisplatin/Topotecan
Descripción

Cisplatin or Cisplatin/Topotecan

Tipo de datos

integer

MVAC
Descripción

MVAC

Tipo de datos

text

If the Protocol Regimen is scheduled to be given Today
Descripción

Protocol Regimen Schedule

Tipo de datos

integer

Was any assistance given to the patient in completing the QoL assessment?
Descripción

QoL assessment completion

Tipo de datos

boolean

If assistance was provided, please describe below how the patient was helped:
Descripción

Assistance to patient

Tipo de datos

text

If the questionnaire was not completed, please indicate why:
Descripción

reason for uncompleted questionnaire

Tipo de datos

integer

If other reason, please specify below
Descripción

Other reason

Tipo de datos

text

Similar models

GOG Toxicity Case Summary

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Administrative data
Type
Item
Type
text
Reported
Item
Reported by
text
Telephone
Item
Telephone
integer
Grade
Item
Grade
text
Protocol Number
Item
Protocol Number
integer
Regimen
Item
Treatment Regimen
text
C0949219 (UMLS CUI [1])
Patient Initials
Item
Patient Initials
text
C25191 (NCI Thesaurus ValueDomain)
C2986440 (UMLS CUI-1)
C16960 (NCI Thesaurus ObjectClass)
C25536 (NCI Thesaurus Property)
Hospital
Item
Name of the hospital
text
C0019994 (UMLS CUI [1])
Gynecologic Oncology Group Number
Item
GOG #
integer
Item Group
Demographics
Date of report
Item
Date report submitted
date
Age
Item
Age
integer
C0001779 (UMLS CUI [1])
Weight
Item
Weight
float
C0005910 (UMLS CUI [1])
Height
Item
Height
integer
C0005890 (UMLS CUI [1])
Body Surface Area
Item
Body Surface Area (m^2)
float
C25209 (NCI Thesaurus ValueDomain)
C0005902 (UMLS CUI-1)
C16960 (NCI Thesaurus ObjectClass)
C25157 (NCI Thesaurus Property)
Diagnosis
Item
Diagnosis
text
C0011900 (UMLS CUI [1])
Item Group
Description
Item
Type of previous treatment
integer
Code List
Type of previous treatment
CL Item
Surgery (1)
CL Item
Radiotherapy (2)
CL Item
Chemotherapy (3)
Administration Start Date
Item
Start date of administration
date
Administration End Date
Item
End date of administration
date
Drug
Item
Drug
text
C2347852 (UMLS CUI [1])
Total Daily Dose
Item
Total Daily Dose
text
C2348070 (UMLS CUI [1])
Route
Item
Route
text
C0013153 (UMLS CUI [1])
Item Group
Protocol Treatment
Date of protocol initiation
Item
Date this protocol was initiated
date
previous toxicity on this protocol
Item
previous toxicity on this protocol
text
Course # for this toxicity
Item
Course # for this toxicity
integer
Date course started
Item
Date this course started
date
Item Group
Drugs and Doses for this Course
Drug
Item
Drug
text
Dose
Item
Dose
text
Route
Item
Route
text
Item Group
Cumulative Totals to Date
Drug
Item
Drug
text
Dose
Item
Dose
text
Route
Item
Route
text
Item Group
Serious Adverse Event
Item
Was patient hospitalized for reaction?
text
Code List
Was patient hospitalized for reaction?
CL Item
Yes (1)
CL Item
No (2)
CL Item
N/A (3)
Item
Was treatment with suspected drug reduced in dosage?
text
Code List
Was treatment with suspected drug reduced in dosage?
CL Item
Yes (1)
CL Item
No (2)
CL Item
N/A (3)
Item
Did reaction abate?
text
Code List
Did reaction abate?
CL Item
Yes (1)
CL Item
No (2)
CL Item
N/A (3)
Item
Was drug reintroduced or dose increased?
text
Code List
Was drug reintroduced or dose increased?
CL Item
Yes (1)
CL Item
No (2)
CL Item
N/A (3)
Item
Did reaction reappear?
text
Code List
Did reaction reappear?
CL Item
Yes (1)
CL Item
No (2)
CL Item
N/A (3)
Item Group
Pretreatment Counts for this Course
Item
Test
integer
Code List
Test
CL Item
Platelets (1)
CL Item
WBC (2)
CL Item
Granulocytes (3)
CL Item
HGB (4)
CL Item
HCT (5)
Date
Item
Date taken
date
Item Group
Nadir Counts
Item
Test
integer
Code List
Test
CL Item
Platelets (1)
CL Item
WBC (2)
CL Item
Granulocytes (3)
CL Item
HGB (4)
CL Item
HCT (5)
Date taken
Item
Date taken
date
Item Group
GOG #
Disease sites
Item
Sites of metastatic disease?
text
Concurrent non-malignant disease
Item
Concurrent non-malignant disease?
text
Concurrent non-protocol medication
Item
Concurrent non-protocol medication?
text
history of organ dysfunctions
Item
History of any major organ dysfunctions?
text
Comment
Item
Comment
text
Item Group
Quality of Life Cover Sheet (Investigator's details)
Date
Item
Date of Form
date
Patient name
Item
text
C1299487 (UMLS CUI [1])
Gynecologic Oncology Group Number
Item
GOG #
integer
Item Group
Time of Today's Assessment
Item
Cisplatin or Cisplatin/Topotecan
integer
Code List
Cisplatin or Cisplatin/Topotecan
CL Item
Baseline (1)
CL Item
Pre-course 2 (2)
CL Item
Pre-course 5 (3)
CL Item
Nine month follow-up (4)
Item
MVAC
text
Code List
MVAC
CL Item
Baseline (1)
CL Item
Pre-course 2 (2)
CL Item
Pre-course 4 (3)
CL Item
Nine month follow-up (4)
Item
If the Protocol Regimen is scheduled to be given Today
integer
Code List
If the Protocol Regimen is scheduled to be given Today
CL Item
Chemotherapy will be given today without delay (1)
CL Item
Chemotherapy will be given today but was delayed (2)
CL Item
Chemotherapy will not be given because patient is off study treatment (3)
QoL assessment completion
Item
Was any assistance given to the patient in completing the QoL assessment?
boolean
Assistance to patient
Item
If assistance was provided, please describe below how the patient was helped:
text
Item
If the questionnaire was not completed, please indicate why:
integer
Code List
If the questionnaire was not completed, please indicate why:
CL Item
The patient refused due to illness (1)
CL Item
The patient refused for reasons other than illness (2)
CL Item
The questionnaire was not given due to institutional error (3)
CL Item
The patient is now off treatment and cannot be contacted even by phone (4)
CL Item
The patient has died (5)
CL Item
Other (6)
Other reason
Item
If other reason, please specify below
text

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial